Lung cancer lung carcinoma
Conditions
Interventions
None listed
Sponsors
HollandPTC
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - > 18 years old at the time of signing informed consent - Patients receiving curative intent proton therapy for lung cancer - Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician - Written Informed consent obtained
Exclusion criteria
Exclusion criteria: - Pacemaker or ICD - Pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The endpoints of the study are divided in the endpoint for the first and the second part of the study: Part I Quantification of the accuracy of phase matching, expressed in the resemblance between the kV-images and the Digitally Reconstructed Radiographs (DRRs) of the individual phases of the 4DCT. Part II The alignment between the kV-image, used as a surrogate for the FLASH beam, and the DRR of the predetermined phase of the 4DCT. The study procedures are further explained in the protocol section 5.2. | — |
Countries
Netherlands
Outcome results
None listed